The Rhesus Macaque CCR3 Chemokine Receptor Is a Cell Entry Cofactor for HIV-2, but Not for HIV-1  by Sol, Nathalie et al.
The Rhesus Macaque CCR3 Chemokine Receptor Is a Cell Entry
Cofactor for HIV-2, but Not for HIV-1
Nathalie Sol,* Carole Tre´boute,* Emmanuel Gomas,* Franc¸oise Ferchal,† Barbara Shacklett,‡ and Marc Alizon*,1
*INSERM U.332, Institut Cochin de Ge´ne´tique Mole´culaire (ICGM), 22 rue Me´chain, 75014 Paris, France; †Laboratoire de Virologie,
Hoˆpital Saint-Louis, 1 av. Cl. Vellefaux, 75010 Paris, France; and ‡CNRS, UPR-415, ICGM, 75014 Paris, France
Received June 26, 1997; returned to author for revision September 17, 1997; accepted October 31, 1997
The eotaxin receptor (CCR3) is a CD4-associated coreceptor for human immunodeficiency virus type 1 (HIV-1) and type 2
(HIV-2). By comparison with other chemokine receptors, such as CCR5 and CXCR4, the primary sequences of human CCR3
and its rhesus macaque homolog were markedly different in their extracellular domains. Human CD41 cells expressing CCR3
from either human or macaque origin could be infected by HIV-2, with apparently similar efficiency, but only cells expressing
human CCR3 could be infected by HIV-1. It suggests that HIV-1 and HIV-2 envelope proteins interact differently with the CCR3
coreceptor. HIV-1 could infect cells expressing chimeric human/macaque CCR3 bearing either the first and second, or the
third and fourth extracellular domains of human CCR3. As previously observed for CCR5, there seems to be a certain
functional redundancy between domains supporting the coreceptor activity of CCR3. In spite of their close genetic
relationship to HIV-2, two macaque simian immunodeficiency virus strains were apparently unable to use the CCR3
coreceptor from either human or simian origin. © 1998 Academic Press
INTRODUCTION
Chemokine receptors are G protein-coupled receptors
with seven membrane-spanning domains. Members of
this family behave as CD4-associated coreceptors for
the human and simian immunodeficiency viruses (HIV-1,
HIV-2, and SIV). Interaction of the viral surface envelope
protein with the CD4/coreceptor complex is thought to
initiate a series of events eventually leading to mem-
brane fusion and cell entry (reviewed in Moore et al.,
1997). The principal HIV-1 coreceptors seem to be the CC
(or b) chemokine receptor CCR5 and the CXC (or a)
chemokine receptor CXCR4. The former is used by most
primary HIV-1 isolates, whether they are macrophage-
tropic (M-tropic), T cell-tropic (T-tropic), or dual-tropic,
while CXCR4 can be used by T-tropic and dual-tropic
HIV-1, and by viral strains adapted ex vivo to replication
in CD41 cell lines (cell line-adapted strains) (Simmons et
al., 1996). A number of HIV-1 strains were also found to
infect CD41 cells expressing CCR3, a receptor for the CC
chemokine eotaxin (Choe et al., 1996; Dittmar et al., 1997;
Doranz et al., 1996). However, this activity of CCR3 was
not observed in all studies (Deng et al., 1996; Dragic et
al., 1996). CCR3 is primarily expressed in eosinophils
(Ponath et al., 1996), but was also detected in microglial
cells and might play a role in the infection of the central
nervous system by HIV-1 (He et al., 1997). Two other b
chemokine receptors, CCR-2b and US28, the latter en-
coded by the human cytomegalovirus (CMV), could me-
diate HIV-1 entry in CD41 cells, or their fusion with cells
expressing HIV-1 envelope proteins, but a role for these
cofactors in vivo has not been established (Doranz et al.,
1996; Pleskoff et al., 1997b). More recently, two orphan
receptors related to the chemokine receptor family, des-
ignated STRL33 (or ‘‘bonzo’’) and gpr15 (or ‘‘bob’’), were
found to behave as possible HIV-1 coreceptors (Liao et
al., 1997; Deng et al., 1997).
Chemokine receptors also seem to be cell entry co-
factors for HIV-2 and for the HIV-2-related simian viruses
from rhesus macaque (SIVmac) and sooty mangabey
(SIVsm). Cell line-adapted HIV-2 strains were found to
infect CD41 cells expressing either CXCR4, CCR5, or
US28 (Pleskoff et al., 1997b) and CD4-negative cells
expressing CXCR4, CCR3, or the orphan receptor V28
(Endres et al., 1996; Reeves et al., 1997). In spite of their
ability to replicate in human T-cell lines and their close
genetic relationship with HIV-2, SIVmac and SIVsm were
apparently unable to use CXCR4, either from human or
macaque origin, but they infected CD41 cells expressing
either the human or the macaque CCR5 (Chackerian et
al., 1997; Chen et al., 1997; Edinger et al., 1997). Several
CD41 cell lines of human or nonhuman origin are per-
missive to infection by HIV-2 and/or SIV and not by HIV-1
(Clapham et al., 1991; McKnight et al., 1994; Chackerian
et al., 1995). A possible explanation is the existence of
coreceptors accessible to HIV-2 and/or SIV and not to
HIV-1. At the moment, only the orphan receptor gpr1 was
shown to mediate entry of SIVmac, but not HIV-1 (Farzan
et al., 1997). Its ability to mediate HIV-2 entry is unknown.
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However, cells expressing the STRL33/bonzo or gpr15/
bob receptors seem to be more susceptible to infection
by HIV-2 and/or SIV than HIV-1 (Liao et al., 1997; Deng et
al., 1997). In the case of nonhuman cells, it can also be
envisioned that genetic differences in the structure of
CCR5, CXCR4, or CCR3 prevent their functional interac-
tion with HIV-1, while allowing their interaction with HIV-2
or SIV. Different cell lines derived from rhesus macaque
tissues, in particular the mammary tumor cell line CMMT
and its sMAGI derivative, are resistant to HIV-1 but per-
missive to HIV-2 or SIVmac infection (Chackerian et al.,
1995). Also, rhesus macaque peripheral blood mononu-
clear cells (PBMC) are relatively resistant to HIV-1 infec-
tion, but readily infected by HIV-2 (Luciw et al., 1995). The
ability of the macaque CCR5 and CXCR4 to mediate
HIV-1 infection suggests that other coreceptors must
support the selective permissivity of macaque PBMC and
cell lines to HIV-2 and SIV. Here, we have addressed the
possible coreceptor activity of the macaque CCR3 for
HIV-1, HIV-2, and SIVmac.
RESULTS
Human and simian CCR3
The ORFs encoding b chemokine receptors are intron-
less sequences, allowing straightforward PCR amplifica-
tion from genomic DNA. The rhesus macaque and Afri-
can green monkey (AGM) CCR3 ORFs were therefore
amplified by PCR performed on DNA from sMAGI or
COS-1 cells, respectively, using primers derived from the
human CCR3 gene (Sol et al., 1997). The human and
simian CCR3 ORFs were sequenced and found to en-
code 355 amino acids (aa). A relatively important degree
of divergence was observed between human CCR3
(Ponath et al., 1996) and its macaque or AGM homologs.
There were 29 aa substitutions (8.2% aa difference) with
the former and 27 aa substitutions (7.6% aa difference)
with the latter (Fig. 1). As could be expected, the ma-
caque and AGM CCR3 sequences were more closely
related to one another (3.7% aa difference) than to human
CCR3. By comparison, CCR5 and CXCR4 were more
highly conserved across primate species than CCR3.
Indeed, human and macaque CCR5 differed by 2.2%, and
CXCR4 from these two species differed by 1.7% (Chen et
al., 1997).
The human and simian CCR3 differed mainly in their
amino terminal extracellular domains (e1) and in their
extracellular loops (e2, e3, e4), while the transmembrane
domains (TM1–TM7) and intracytoplasmic domains (i1–
i4) were more highly conserved. We noted important
charge differences between the e3 domains of human
CCR3 (net charge 26), macaque CCR3 (net charge 21),
and AGM CCR3 (net charge 23).
Coreceptor activity of macaque CCR3
The coreceptor activity of different chemokine recep-
tors for HIV-1 and HIV-2 was first tested in a CD41
human glioma cell line (U373MG-CD4), which is naturally
resistant to HIV-1 infection and to fusion with cells ex-
pressing the HIV-1 envelope proteins (Harrington and
FIG. 1. Amino acid sequences of the human, rhesus macaque, and African green monkey (AGM) CCR3. The predicted transmembrane domains
(TM1 to TM7) are underlined. e1 to e4, extracellular domains; i1 to i4, intracellular domains. The position of the NheI restriction site used to construct
the human/macaque CCR3 chimeras is shown in TM4. The human CCR3 sequence was identical to the report of Ponath et al. (1996).
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Geballe, 1993). We have previously observed that
U373MG-CD4 cells transfected with CXCR4, CCR5, or
US28 expression vectors could be infected by different
HIV-1 strains, and by the cell line-adapted HIV-2 strain
ROD (Pleskoff et al., 1997a,b). The U373MG-CD4 cells
are stably transfected by a Tat-inducible LTR-lacZ re-
porter gene. Infection by HIV-1 or HIV-2 can therefore be
detected by scoring cells expressing a high level of
b-galactosidase activity. The expression of CXCR4 al-
lowed infection of U373MG-CD4 cells by cell line-
adapted HIV-1 (LAI) and HIV-2 (ROD) strains, but not by
M-tropic HIV-1 (ADA, YU-2) or by four primary HIV-1 or
HIV-2 isolates (Table 1). Primary and M-tropic strains, as
well as ROD, infected U373MG-CD4 cells expressing
either human CCR5 or human CCR3 (Table 1). For all the
HIV-1 and HIV-2 strains tested, the susceptibility to in-
fection was higher for CCR51 cells than for CCR31 cells.
This difference between CCR51 and CCR31 cells was
more pronounced in the case of M-tropic HIV-1 strains
(ADA, YU-2).
The susceptibility to infection with HIV-2 ROD was
similar for U373MG-CD4 cells expressing either human
CCR3, or its macaque homolog (Table 1). Although viral
titers were lower, HIV-2 isolates apparently infected cells
expressing human or macaque CCR3 with similar effi-
ciency (Table 1). In contrast, only U373MG-CD4 cells
expressing human CCR3 were infected by the four M-
tropic and primary HIV-1 tested (Table 1). In this experi-
ment, HIV-1 strains were apparently unable to use ma-
caque CCR3 as their coreceptor.
The coreceptor activity of CCR3 and CCR5 was also
tested by transient transfection in the HeLa-P4 cell line.
The M-tropic HIV-1 strains YU-2 and ADA could infect
cells expressing human CCR5 or human CCR3, but not
macaque CCR3 (Table 2), thus confirming its apparent
lack of HIV-1 coreceptor activity. Although the numbers of
infected cells were relatively low, a primary HIV-2 isolate
(BAJE) could infect HeLa-P4 cells expressing either hu-
man CCR3 or its macaque homolog. The permissivity of
HeLa-P4 cells to infection by ROD precluded its use in
this experiment.
Two SIVmac strains could infect HeLa-P4 cells ex-
pressing human CCR5, but not human or macaque CCR3
(Table 2). Accordingly, the HeLa-P5 cells, derived from
HeLa-P4 and stably expressing CCR5 were permissive to
SIVmac infection, while the HeLa-P3, stably expressing
CCR3, were resistant (Table 3). As expected, the sMAGI
cells were readily infected by SIVmac or HIV-2, but not
HIV-1 (Table 3).
Surface expression of chemokine receptors
The functional differences between human and ma-
caque CCR3 might have been related to their respec-
tive levels of expression in transfected cells. It can
indeed be envisioned that HIV-1 and HIV-2 do not have
the same requirements in terms of coreceptor density
at the cell surface. To address this possibility, we have
used modified forms of chemokine receptors, bearing
TABLE 1
HIV-1 and HIV-2 Infection of U373MG-CD4 Cells Expressing Different Chemokine Receptors
Viral strains
CXCR-4 CCR5 CCR3 CCR3 Nonea
Human Human Human Macaque
HIV-1 ADA 14, 15 200, 250 50, 45 15, 14 14
HIV-1 YU-2 18, 16 320, 340 100, 85 20, 18 16
HIV-1 MAI 15, 16 80, 90 70, 70 18, 20 15
HIV-1 LEJE 18, 15 60, 50 35, 40 15, 15 15
HIV-1 LAI 620, 600 10, 12 10, 10 10, 10 10
HIV-2 ROD 560, 600 450, 450 320, 300 300, 300 30
HIV-2 BATI 16, 16 50, 50 40, 40 28, 30 15
HIV-2 BAJE 16, 18 50, 50 35, 30 30, 30 15
Note. No. of infected cells per well. Infections were performed in duplicate wells of 12-well trays (excepted for mock-transfected cells). Cells were
fixed and stained for b-galactosidase activity (X-Gal) 60 h after infection. In each well, blue-stained cells were counted under 203 magnification
(numbers .100 were extrapolated from randomly selected fields).








CCR5 CCR3 CCR3 Nonea
Human Human Macaque
HIV-1 ADA 200 20 3 1
HIV-1 YU-2 450 45 5 1
HIV-2 BAJE 60 10 8 1
SIVmac251 400 0 0 1
SIVmac239 500 0 1 0
Note. No. of infected cells per well. Six-well plates. Cells were fixed
and stained with X-Gal 48 h after infection. Blue-stained cells were
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the epitope of a monoclonal antibody (9E10) at their
amino terminus. Epitope-tagged receptors can there-
fore be detected at the surface of transfected cells by
flow cytometry. We previously found that this epitope
tag did not affect the coreceptor activity and strain
selectivity of CXCR4 or CCR5 (Pleskoff et al., 1997b).
Epitope-tagged CCR3 from either human, macaque or
AGM origin were transfected into HeLa-P4 cells, along
with a vector allowing expression of the green fluo-
rescent protein (GFP). Cells were stained with 9E10
and a phycoerythrin (PE)-conjugated secondary anti-
body yielding red fluorescence and analyzed by flow
cytometry (Fig. 2A). For all epitope-tagged receptors,
the fraction of GFP1 cells were similar, indicating a
similar efficiency of transfection (Fig. 2B). In contrast,
there were marked differences between the fractions
of PE1 cells, indicating that epitope-tagged chemo-
kine receptors were not expressed at the same level.
As previously observed (Choe et al., 1996; Sol et al.,
1997), human CCR3 was expressed at a much lower
level than CXCR4 and CCR5 (Fig. 2B). The percentages
of PE1 cells and the mean fluorescence intensities
were similar for the human and macaque CCR3, while
the AGM CCR3 was expressed at a slightly higher
level. These experiments suggested that the lack of
coreceptor activity of macaque CCR3 for HIV-1 was not
related to a lower level of expression in transfected
cells, by comparison with human CCR3.
Chimeric CCR3
To better define the domain(s) and genetic differences
responsible for the observed phenotype differences be-
tween human and macaque CCR3, two chimeric recep-
tors, designated h-m and m-h (Fig. 3A), were constructed
by recombining the ORFs at a common NheI site (Fig. 1).
These constructs and the parental receptors were ex-
pressed in HeLa-P4 cells by transient transfection, and
cocultures were performed with HeLa cells stably ex-
pressing envelope proteins from the M-tropic HIV-1
strain ADA (Pleskoff et al., 1997b). Cells expressing hu-
man CCR3, but not the macaque homolog, fused with
these Env1 cells (Fig. 3B). Unexpectedly, the expression
of each of the chimeric CCR3s allowed fusion of HeLa-P4
and Env1 cells, with a relatively good efficiency since the
numbers of syncytia were about 40% of what was ob-
served with human CCR3. Therefore, both the amino-
terminal and the carboxy-terminal halves of human CCR3
could form a functional HIV-1 coreceptor when they were
fused to the complementary domains derived from ma-
caque CCR3.
DISCUSSION
Our experiments confirmed that expression of the
CCR3 chemokine receptor in CD41 cells allows their
infection by HIV-1 or by HIV-2. As previously observed
(Choe et al., 1996; Sol et al., 1997), CCR3 was expressed
at a relatively low level in transfected cells, by compar-
ison with other chemokine receptors, in particular CCR5
or CXCR4. This may explain the apparent lack of HIV
coreceptor activity of CCR3 in some studies (Deng et al.,
1996; Dragic et al., 1996), or the lesser susceptibility to
HIV-1 infection of cells expressing CCR3, by comparison
with cells expressing CCR5 (Choe et al., 1996). We also
observed that M-tropic HIV-1 infected CCR51 cells more
efficiently than CCR31 cells. However, several primary
HIV-1 isolates and HIV-2 strains such as ROD infected
CCR51 or CCR31 cells with apparently similar efficiency,
in spite of the lower level of expression of CCR3. This
result should strengthen the view that CCR3 can be used
as a coreceptor by HIV-1 and HIV-2 in vivo. This view is
chiefly supported by the HIV-1 inhibitory effects of anti-
CCR3 antibodies and eotaxin in microglial cells (He et al.,
1997), which represent the main HIV-1 target cells in the
central nervous system (Watkins et al., 1990). However, it
cannot be ruled out that CCR3 plays a role in the infec-
tion of other cell types by HIV-1, since CCR3 transcripts
were detected in clones of T lymphocytes (Liao et al.,
1997). Also, the relative permissivity of eosinophils to
productive HIV-1 infection in vitro might be related to
their high level of CCR3 expression (Freedman et al.,
1991).
The human and macaque forms of CXCR4 or CCR5 are
closely related in terms of primary sequence and were
found to display a similar coreceptor activity for HIV-1
TABLE 3
Expression of Chemokine Receptors in CD41 Cell Lines and
Infection by HIV-1, HIV-2, and SIVmac


















None 1, 0 1, 0 6, 5 10, 15
HIV-1 ADA 2, 0 100, 100 40, 35 19, 20
HIV-1 YU-2 2, 2 350, 360 70, 80 18, 20
HIV-1 MAI 0, 1 240, 220 35, 45 15, 18
HIV-1 LEJ 0, 0 250, 220 45, 40 16, 14
HIV-1 LAI 280, 260 350, 340 300, 300 25, 25
HIV-2 ROD 103, 103 103, 103 103, 103 960, 990
HIV-2 BATI 15, 12 140, 160 45, 40 250, 280
HIV-2 BAJE 8, 6 100, 120 45, 45 100, 100
SIVmac251 1, 0 160, 150 10, 12 250, 270
SIVmac239 1, 1 320, 340 10, 10 400, 360
Note. No. of infected cells per well. Twelve-well plates. Cells were
fixed and stained with X-Gal 48 h after infection. Blue-stained cells
were scored as in Table 1.
a HeLa-P3 cells were treated with 5 mM sodium butyrate to increase
expression of CCR3.
b Expression of chemokine receptors was sought for by RT-PCR.
Cell lines:
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(Chackerian et al., 1997; Chen et al., 1997; Edinger et al.,
1997). By comparison, the genetic divergence between
human CCR3 and its rhesus macaque or AGM homologs
was relatively high. In our experiments, expression of
macaque CCR3 or human CCR3 in CD41 cells allowed
their infection by HIV-2. In contrast, only human CCR3
FIG. 2. Cell surface expression of epitope-tagged chemokine receptors. HeLa-P4 cells were cotransfected with expression vectors for epitope-
tagged CCR5, CXCR-4, or CCR3 and for GFP (6:1 ratio). Cells were harvested 40 h later and stained with the anti-tag antibody (9E10) and a
phycoerythrin(PE)-conjugated secondary antibody. (A) Two-color flow cytometry analysis for red fluorescence (x axis, chemokine receptor expression)
and green fluorescence (y axis, GFP expression). (B) For each cotransfection, histograms represent the fraction of cells with green fluorescence
intensity .40 (arbitrary units), indicating the efficiency of transfection, and among this subset of cells, the fraction of cells with red fluorescence
intensity .20 (arbitrary units), expressing detectable levels of chemokine receptors at their surface.
217HIV CORECEPTOR ACTIVITY OF MACAQUE CCR3
allowed infection by all HIV-1 strains tested or fusion with
cells expressing HIV-1 envelope proteins. This apparent
lack of HIV-1 coreceptor activity could not be explained
by a lower surface expression of macaque CCR3, by
comparison with human CCR3. The simpler explanation
is that the HIV-1 and HIV-2 surface envelope proteins
(gp120) interact differently with human CCR3. The do-
main(s) interacting with HIV-1 gp120 might not be con-
served enough in macaque CCR3 to support HIV-1 co-
receptor activity. There are numerous indications that
CCR5, or CXCR4, interacts differently with HIV-1 and
HIV-2, or even with two genetically related HIV-1 strains
(see for example Rucker et al., 1996; Picard et al., 1997;
Brelot et al., 1997). This hypothesis could be confirmed
by the identification of the human CCR3 domains sup-
porting its coreceptor activity for HIV-1 and for HIV-2.
However, experiments with chimeric human/macaque
CCR3 suggest that this task is not straightforward. In-
deed, chimeric CCR3 bearing either the first two extra-
cellular domains (e1, e2) of human CCR3, or its third and
fourth extracellular domains (e3, e4) behaved as HIV-1
coreceptors. It suggests a certain functional redundancy
between human CCR3 domains. Similar conclusions
have been reached in studies aimed at defining the
functional domains of CCR5 (Rucker et al., 1996; Atchin-
son et al., 1996; Bienasz et al., 1997; Picard et al., 1997).
The macaque simian immunodeficiency virus (SIV-
mac) is more closely related to HIV-2 than to HIV-1. All the
SIVmac strains tested could infect CD41 cells express-
ing CCR5, but not CXCR4, from either human or macaque
origin (Chackerian et al., 1997; Chen et al., 1997; Edinger
et al., 1997). The two SIVmac strains we have tested were
also apparently unable to infect cells expressing human
or macaque CCR3. Other SIV strains should be tested
before it can be concluded that only HIVs have the ability
to use the CCR3 and CXCR4 coreceptors.
A number of CD41 cell lines such as the macaque
sMAGI cells used in this study (Chackerian et al., 1995),
the human glioma cell line U87MG-CD4 (Clapham et al.,
1991), or the mink cell line Mv-1-Lu (McKnight et al., 1994)
have been shown to be permissive to infection by HIV-2
and or SIV, but not by HIV-1. By using reverse tran-
scriptase (RT)-PCR techniques, we could not detect
CCR5, CXCR4, and CCR3 transcripts in sMAGI and
U87MG-CD4 cells (data not shown), suggesting that their
permissivity to HIV-2 was due to other coreceptors. After
this study was completed, U87MG cells were reported to
express the orphan receptors STRL33/bonzo (Deng et al.,
1997) and gpr1 (Farzan et al., 1997). The latter is a
coreceptor for SIVmac, but not for the HIV-1 strains
tested. Its HIV-2 coreceptor activity has not been deter-
mined. Expression of STRL33/bonzo allows infection of
CD41 cells by HIV-2 and SIVmac, but also by some HIV-1
strains, although less efficiently (Deng et al., 1997; Liao et
al., 1997). It can therefore be envisioned that the selec-
tive permissivity of U87MG-CD4 cells to HIV-2 is due to a
low level of expression of STRL33/bonzo or to other
coreceptors yet to be discovered.
MATERIALS AND METHODS
Viral strains
Primary HIV-1 and HIV-2 were isolated from PBMC of
seropositive asymptomatic individuals, and propagated
in normal donors’ PBMC. Details are presented else-
where (Sol et al., 1997). The HIV-1 strains LAI (cell line-
adapted) (Peden et al., 1991), ADA (actually a recombi-
nant LAI with env from the M-tropic strain ADA) (Pleskoff
et al., 1997b), and YU-2 (M-tropic) (Li et al., 1992) were
produced by transfection of cloned recombinant provi-
ruses into HeLa cells (calcium phosphate precipitation).
The cell line-adapted HIV-2 ROD was also derived from a
molecular clone (Ryan-Graham and Peden, 1995), but the
viral stock was amplified in the T-cell line MT-4. Stocks of
FIG. 3. Coreceptor activity of chimeric human/macaque CCR3. (A)
Schematic representation of wild-type and chimeric CCR3. (B) Core-
ceptor activity was quantitated by expression of wild-type and chimeric
CCR3 in HeLa-P4 cells (LTRlacZ) and scoring syncytia formed upon
coculture (1:1 ratio) with HeLa-Env/ADA (Env1Tat1) or HeLa-DEnv
(Env2Tat1) cells. Fusion of these cell types results in LTRlacZ trans-
activation and high b-galactosidase activity (blue staining with X-Gal).
The HeLa-P4 cells were transfected in six-well trays and treated with 5
mM sodium butyrate, to increase chemokine receptor expression,
before coculture. The HeLa-Env/ADA or HeLa-DEnv cells were added
24 h after transfection. Cocultures were fixed and stained with X-Gal
48 h later. All blue-stained foci were scored. Numbers represent the
mean of two wells.
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SIVmac251 and SIVmac239 (Daniel et al., 1985) were
prepared in the CEMx174 cell line, as described (Luciw
et al., 1992).
Cell lines
The adherent cell lines (HeLa derivatives, sMAGI,
U373MG-CD4, U87MG-CD4) were propagated in Dulbec-
co’s modified Eagle’s medium supplemented with 10%
fetal calf serum, antibiotics (penicillin, streptomycin), and
2 mM glutamine. The HeLa-P4 (Clavel and Charneau,
1994), U373MG-CD4 (Harrington and Geballe, 1993), and
sMAGI (Chackerian et al., 1995) cell lines express human
CD4 and are stably transfected with a HIV-1 long termi-
nal repeat (LTR)–lacZ construct, allowing detection of
infected cells by assaying b-galactosidase activity. The
HeLa-P5 (Pleskoff et al., 1997b) and HeLa-P3 cells (Sol et
al., 1997) stably expressing CCR5 or CCR3, respectively,
are HeLa-P4 derivatives. The HeLa-Env/ADA (Pleskoff et
al., 1997b) and HeLa-DEnv (Schwartz et al., 1994) cell
lines have been described.
Cloning and expression of chemokine receptors
Open reading frames (ORFs) corresponding to chemo-
kine receptors were subcloned downstream of the CMV
immediate–early promoter in the Rc/CMV vector (InVitro-
gen, La Jolla, CA) or in the pCDNA-3 vector (Clontech,
Palo Alto, CA) in the case of epitope-tagged receptors.
The expression vectors for the human CXCR4 (Pleskoff et
al., 1997a), CCR5 (Pleskoff et al., 1997b), and CCR3 (Sol et
al., 1997) have been described previously. The ORFs
encoding CCR3 from macaque and African green mon-
key (AGM) were PCR-amplified from DNA of sMAGI cells
and or COS-1 cells, respectively, using previously de-
scribed primers (Sol et al., 1997), complementary to se-
quences of the human CCR3 gene immediately flanking
its coding sequence (Ponath et al., 1996). The nucleotide
sequences of the CCR3 ORFs were determined on an
automated DNA sequencer (Applied Biosystems). They
were deposited at the EMBL nucleotide sequence data-
base under Accession Nos. Y13775 (macaque CCR3)
and Y13776 (AGM CCR3).
Detection of epitope-tagged chemokine receptors
Chemokine receptor ORFs were amplified with prim-
ers allowing their subcloning at a BamHI site in the
pCDNA3-tag vector (Pleskoff et al., 1997b). It results in
the in-frame fusion of the chemokine receptor down-
stream from the amino acid sequence MGPEQKLISEED-
LGSG, which contains the epitope of the 9E10 anti-
human c-MYC monoclonal antibody (Evan et al., 1985).
For flow cytometry experiments, HeLa-P4 cells were co-
transfected with a vector expressing a tagged chemo-
kine receptor and with the EGFP-N1 vector (Clontech)
expressing the green fluorescent protein (GFP) in a 6:1
ratio. Cells were detached with phosphate-buffered sa-
line (PBS) containing 1 mM EDTA 40 h after transfection
and then stained with 9E10 (Boehringer, Mannheim, Ger-
many) and then with a phycoerythrin (PE)-conjugated
goat anti-mouse antiserum (Dako, Glostrub, Denmark),
as described (Pleskoff et al., 1997b).
Infectivity assays
The infections of LTR-lacZ cell lines (HeLa-P4 and
derivatives, sMAGI) were performed in 12-well trays. The
inoculum (approximately 20,000 cpm of RT activity for
primary HIV isolates, 10 to 25 ng of p24 for other strains)
was added to subconfluent monolayers and left in con-
tact with cells for 2 h. The HeLa-P3 cells (CCR31) were
treated with 5 mM sodium butyrate (Sigma) in order to
increase expression of CCR3 from the CMV promoter.
This treatment was previously found to increase the
infectious titers, without affecting strain specificity (Choe
et al., 1996; Sol et al., 1997). The drug was added to the
medium 24 h before infection. It was not present during
or after virus–cell contact. The U373MG-CD4 cells tran-
siently expressing chemokine receptors were infected
36 to 40 h after transfection, as described (Pleskoff et al.,
1997a). Cells were washed with PBS, fixed with 0.5%
glutaraldehyde, and stained with the chromogenic sub-
strate X-gal (5-bromo-4-chloro-3-indoyl-b-D-galactopyr-
anoside) 48 h after infection, or 60 h in the case of
U373MG-CD4 cells.
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